Verified Peptides

Sermorelin Research & Scientific Studies

Explore the latest peer-reviewed research and scientific studies

About Sermorelin

Sermorelin is a synthetic GHRH (1-29) analogue used in endocrine research. Supplied as a lyophilized powder for laboratory investigations into physiological GH secretion mechanisms and pituitary signaling pathways in controlled experimental models. Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.

Purity99
Categorypeptide

Latest Research

Featured Study

Growth hormone - releasing hormone antagonists induce autophagy in cancer cells.

Sigdel M et al.Growth Horm IGF Res2025

Recent research on Sermorelin: Growth hormone - releasing hormone antagonists induce autophagy in cancer cells.

Read Full Study on PubMed
Featured Study

A novel approach for the treatment of AML, through GHRH antagonism: MIA-602.

Costoya J et al.Rev Endocr Metab Disord2025

Recent research on Sermorelin: A novel approach for the treatment of AML, through GHRH antagonism: MIA-602.

Read Full Study on PubMed

Additional Studies

Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer Cells.

Gesmundo I et al.Int J Mol Sci2025

Recent research on Sermorelin: Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer Cells.

Read on PubMed

Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate Cancers.

Muñoz-Moreno L et al.Int J Mol Sci2024

Recent research on Sermorelin: Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate Cancers.

Read on PubMed

Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.

Gaumond SI et al.Oncotarget2024

Recent research on Sermorelin: Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.

Read on PubMed

Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.

Thomas A et al.J Mass Spectrom2024

Recent research on Sermorelin: Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.

Read on PubMed

Related Research

Purchase Sermorelin from Verified Peptides

High-purity research peptides with full analytical verification

  • 99% Purity (HPLC Verified)
  • Full Certificate of Analysis
  • Same Day Dispatch
  • Free UK Shipping Over £75
Buy Sermorelin - 99% Purity, Same Day Dispatch

Research Disclaimer

The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.